SDGR

Schrödinger, Inc. (NASDAQ:SDGR) is a computational platform company founded in 1990 and headquartered in New York, New York. The company went public in February 2020 and operates at the intersection of physics-based computational methods and drug discovery. Schrödinger has evolved from a software company serving the pharmaceutical industry into a dual-business model enterprise that both licenses its computational platform to external customers and develops its own proprietary drug candidates. The company serves biopharmaceutical companies, industrial firms, academic institutions, and government laboratories worldwide.